Educational Wellness Information Only
This platform provides peer-reviewed research summaries and educational content about peptides for wellness and optimization purposes. Nothing on this site is intended as medical advice, diagnosis, or treatment. We do not claim any peptide can diagnose, treat, cure, or prevent any disease. Always consult a licensed healthcare provider before beginning any wellness protocol.
Statements on this site have not been evaluated by the FDA. Compounded preparations are subject to applicable state and federal regulations. Availability and eligibility vary.
Epithalon Acetate vs FOXO4-DRI
An educational, source-based comparison of Epithalon Acetate and FOXO4-DRI — how each peptide works, what it's researched for, and what to know before going deeper.
An N-acetylated variant of Epitalon (Ala-Glu-Asp-Gly) designed to improve metabolic stability and oral bioavailability. Research suggests the same telomerase activation and circadian-modulating properties as the parent peptide.
- Telomerase activity and cellular senescence
- Melatonin rhythm regulation
- Age-related immune restoration
- • Preclinical data; limited human clinical trials.
- • Not FDA-approved.
A D-retro-inverso peptide that disrupts the FOXO4-p53 interaction inside senescent cells, selectively triggering their apoptosis while sparing healthy cells in preclinical models.
- Senescent cell clearance
- Tissue function in aged mice
- Fibrotic disease models
- • No human trials; safety and pharmacokinetics in humans unknown.
- • Not FDA-approved.
Epithalon Acetate vs FOXO4-DRI — Key differences
- Class: Epithalon Acetate is classified as Longevity · Circadian, while FOXO4-DRI is Longevity · Senolytic.
- Primary research focus: Epithalon Acetate — telomerase activity and cellular senescence; FOXO4-DRI — senescent cell clearance.
- Tag: Longevity vs Longevity · Senolytic.